Rotavirus C VP6 inhibitors are a class of chemical compounds designed to specifically target and inhibit the VP6 protein of rotavirus C, a structural protein critical for the virus's assembly and function. VP6 is the major component of the inner capsid of the rotavirus, forming a protective layer around the viral RNA and playing a central role in the structural integrity of the viral particle. The VP6 protein also mediates important interactions with other viral proteins during the virus replication cycle, including the formation of the double-layered viral particle (DLP), a key intermediate in the rotavirus life cycle. By inhibiting VP6, these compounds aim to disrupt the assembly of the inner capsid, leading to a breakdown in viral replication and the production of infectious viral particles.
The design of rotavirus C VP6 inhibitors requires a detailed understanding of the protein's structural features, particularly the interactions that allow it to form the icosahedral capsid structure. VP6 forms trimers that assemble into the viral capsid, and inhibitors typically target the interfaces between these trimeric units or key regions involved in capsid stabilization. By binding to these specific regions, inhibitors can prevent the proper assembly of the viral particle, thereby interfering with the virus's ability to protect its genetic material and continue its replication cycle. Achieving high specificity in these inhibitors is crucial to avoid off-target effects, as structural proteins of viruses often share similar features. Researchers utilize structural biology techniques like X-ray crystallography and cryo-electron microscopy to design inhibitors that precisely target VP6, providing valuable insights into the mechanisms of rotavirus assembly and the molecular interactions necessary for viral replication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
An antiviral agent that inhibits viral RNA polymerase, indirectly affecting VP6 by disrupting viral replication. | ||||||
Nitazoxanide | 55981-09-4 | sc-212397 | 10 mg | $124.00 | 1 | |
Interferes with the maturation of viral particles, potentially affecting VP6 assembly and the stability of the viral capsid. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol from green tea that has been shown to inhibit rotavirus, possibly affecting the assembly or function of VP6. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
An inhibitor of cellular and viral enzymes, it could indirectly affect VP6 by altering viral replication or host cell interactions. | ||||||
Guanidine Hydrochloride | 50-01-1 | sc-202637 sc-202637A sc-202637B | 100 g 1 kg 25 kg | $61.00 $310.00 $1975.00 | 1 | |
Affects viral RNA synthesis, potentially influencing the replication process involving VP6. | ||||||
Nelfinavir | 159989-64-7 | sc-507314 | 10 mg | $168.00 | ||
An HIV protease inhibitor that has shown efficacy against rotaviruses, potentially affecting VP6 through disrupted viral protein processing. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
An inhibitor of glycosylation processing in cells, which might affect VP6 by altering glycoprotein maturation in the viral lifecycle. | ||||||
Oseltamivir phosphate | 204255-11-8 | sc-208135 sc-208135A | 10 mg 200 mg | $179.00 $650.00 | 5 | |
Primarily an influenza virus neuraminidase inhibitor, but has been explored for broader antiviral effects which could include impact on rotavirus and VP6. | ||||||